[{"from": "human", "value": "Describe this molecule. [C][C@H1][C][C@H1][C@@H1][C][C][C@@][Branch2][Ring1][P][C@][Ring1][Branch1][Branch2][Ring1][#Branch2][C][C@@H1][Branch2][Ring1][Ring2][C@@H1][Ring1][=Branch2][C@@][Branch1][=N][C][Ring1][=N][=C][C][=Branch1][C][=O][C][=C][Ring1][#Branch1][C][O][C][Branch2][Ring1][C][C][=Branch1][C][=O][C][O][C][=Branch1][C][=O][C][C][C][=Branch1][C][=O][O-1][O].[Na+1]"}, {"from": "gpt", "value": "The molecule is the sodium succinate salt of a synthetic glucocorticoid receptor agonist with immunosuppressive and anti-inflammatory effects. Methylprednisolone sodium succinate is converted into active prednisolone in the body, which activates glucocorticoid receptor mediated gene expression. This includes inducing synthesis of anti-inflammatory protein IkappaB-alpha and inhibiting synthesis of nuclear factor kappaB (NF-kappaB). As a result, proinflammatory cytokine production such as IL-1, IL-2 and IL-6 is down-regulated and cytotoxic T-lymphocyte activation is inhibited. Therefore, an overall reduction in chronic inflammation and autoimmune reactions may be achieved."}]